Submit ICO
Bitcoin(BTC) -0.1% $4871.49
Ripple(XRP) -0.04% $0.478166
Ethereum(ETH) 0.4% $149.416

EpigenCare

Truly Personalized Skincare Based on Epigenetics

Finished

Finished: 5 months 2 weeks ago

Start Date

16th of April 2018

End Date

1st of June 2018

Country: USA

    Restrictions:
  • China
Ticker/Symbol EPIC
Price 1 EPIC = 0.40 USD
TokenType ERC20
Platform Ethereum
Hardcap   20,00
Softcap   0,00
Raised 0,00
ICO Score
4.4
Team:
4.0
Vision:
3.0
Product:
2.0
Profile:
3.8

Info

Scientifically Grounded
How does a consumer know whether a skincare product is truly working for them? EpigenCare is connecting consumers with skincare companies through a direct-to-consumer skincare test and web platform on the Ethereum network. Consumers will be able to receive actionable recommendations of optimized skincare products to use, as well as assess the progress of their skincare routines, based on their skin’s epigenetic profiles. The recommendation engine looks at the functional state of a panel of epigenetic markers strongly correlated with skin quality indicators (e.g., aging, moisture retention, elasticity, etc.), and how skincare product ingredients affect them.
 
A Cyclical Growth Ecosystem
As epigenetics regulates gene function and dynamically changes based on environment stimuli such as skincare product ingredients, it is a perfect fit for a recurring, tokenized business model. EpigenCare’s upcoming platform will be a structured ecosystem that allows skincare companies to target data segments with products that fulfill the recommendation engine’s matching requirements. Consumers that fall within the segment are rewarded with tokens, which can be used to subsidize additional tests (thereby generating additional advertising inventory for companies).
 
Disrupting the Skincare Industry
Our structured ecosystem allows for true leveraging of blockchain technology. The recurring nature of epigenetics allows for a perpetual incentivization model through data tokenization. By associating a transaction hash ID with each purchased test and data segment, we will be able to transparently prove that a consumer’s data is used only for their own benefit, thereby addressing the problem of perceived intrusiveness often associated with commercialized DNA-related testing. EpigenCare’s disruptive innovation introduces a new marketing channel to the $130 billion skincare industry and transform the way companies market their products to consumers through scientifically screened, individualized advertising.
 

Team

William Lee

Chief Executive Officer

Adam Weiwei Li, Md, Ph.d.

Chief Scientific Officer

Jessica Li

Chief Financial Officer

Ashley Pottash

Business Strategy Lead

Stephen Fiser

Software Development Lead

Advisors

Richard Wildnauer, Ph.D.

Business Advisor

James Wang, MD

Dermatology Advisor

Brennan Bennett

Blockchain Advisor

Rebecca Fry, Ph.D.

Epigenetics Advisor

Tim Bukher

Legal Strategy Advisor

Roadmap

Q2, 2017 EpigenCare Inc. Established in New York, USA
Q4 2017 Epigenetic-based Skincare Test Successfully Developed and Proven
Q1 2018 ICO Token Generation Event
Q2 2018 Launch Marketing Campaign for Product Pre-Orders
Q3 2018 Limited Launch of Beta Skincare Test
Q4 2018 Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta
Q1 2019 Launch Consumer Mobile Application
Q2 2019 Launch Official EpigenCare Network Platform
Q3 2019 Retail Distribution Initiative; Deploy API (Application Programming Interface)
Q4 2019 Dermatologist/Spa/Beauty Salon Partnership Initiative
Future Objectives Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application

Medium News

Company Updates and Temporary Pausing of STO
2018-05-21 22:48:02

Company Updates and Temporary Pausing of STO

It has been an exciting few months since we first revealed our project to the public. Progress is being made with EpigenCare’s skincare test and product ingredient matching algorithm and we are continuing to refine the collection method and data analysis pipeline towards commercialization. Lately there has been significant media attention to our technology, with feature mentions in a wide array of industry and consumer publications including Cosmetics Business and Refinery29. We also won a skincare technology competition hosted by Johnson & Johnson Innovation, giving us $25,000 seed money and accelerator space at JLABS in New York City. Just last week, CEO William Lee presented EpigenCare’s technology at HAPPI magazine’s Anti-Aging Conference with the New York Society of Cosmetic Chemists.

As many of you know, part of our intended fundraising process was to be through an initial coin offering. For months, we did our due diligence and went through multiple revisions to structure our offering to be fully compliant with United States laws, particularly those of the Securities & Exchange Commission. This resulted in a dual token system, with the initial coin offering evolving into a security token offering (STO) that was separate from the utility token that is to operate on our platform. We launched the STO on a low-key basis to test the waters, and we have now ultimately concluded that the current environment for such a structured offering is not ideal. Therefore, we are making the decision to temporarily pause access to the publicly available offering of the tokens through our website’s investment platform, effective immediately. This decision was based on the following factors:

Global cryptocurrency enthusiasts are still mostly focused on short-term trading of “utility” tokens rather than security tokens. Currently, true security tokens require a dual token system in the United States to be compliant with SEC regulations, which does not seem to be currently attractive for traditional cryptocurrency investors while other investment options exist worldwide.

There is currently a downturn on the cryptocurrency as well as a significant loss of appeal for ICOs in the United States. However, there is indication of various government entities, including US Congress, softening up on their cryptocurrency and ICO stance. Thus, we may be better positioned for an offering when the market is more positive and cryptocurrency-related regulations are less ambiguous in the US.

The amount of marketing money and personnel resources spent to maintain an ICO/STO would be better spent towards actual product development and commercialization. Rather than compete in a global ICO market with foreign projects that have less regulations than in the USA, we would rather be focused on acquiring customers and building a world-class product and platform for mainstream adoption.

We have attracted private investor interest, subsequently providing us with alternative sources of funding. We are currently in discussion with investment groups and VC firms and this outcome will determine when we may resume the security token offering.

This was a difficult decision to make but we feel that at this time this is the best route for us to move forward with a product-focused initiative. Again, only access to the publicly-available Regulation S/D 506(c) security token offering through our website portal is temporarily paused — we will make a public update should it resume in the near future. Our limited offering of equity is still available in alternative crowdfunding platforms.

In the meantime, we are exploring investment channels through traditional VC firms. In late June, we will be expanding to the Johnson & Johnson JLAB facility and working with industry leaders and potential VC investors, which will expedite our commercialization process. We are keen to bring our products to the market soon, and will continue to communicate our developments with the public.

If you have any questions about this matter or your existing investments, please contact investment@epigencare.com. Additional information will be sent to existing investors shortly.

A Dual Token Structure to Solve the Catch-22 of SEC “Compliant” Initial Coin Offerings
2018-04-17 14:03:19

A Dual Token Structure to Solve the Catch-22 of SEC “Compliant” Initial Coin Offerings

We just officially launched the sale of our EPIC tokens — a security token offering that includes revenue sharing rights and, more notably, an option to convert to equity ownership. At the same time, our blockchain-based platform for data provenance of usage of the epigenetic profiles we are generating is facilitated by a separate utility token called ECARE. The journey to this dual token structure was a long and challenging one, starting from as far back as August of 2017 in the midst of growing interest in Initial Coin Offerings (ICOs). Eight months and multiple attorneys later, we have finally launched a digital token offering that is fully compliant with SEC rules. And by fully compliant, we mean to the most thorough extent that is possible with the nature of digital tokens and traditional US securities laws. To understand how we got here, we need to take a step back and establish some background for our story that follows.

Tokenizing for Blockchain Utility

EpigenCare is offering a skincare test that generates an epigenetic skin quality profile of the consumer based on his or her DNA. A digital platform is being built such that one’s epigenetic profile can be matched to skincare products on the market that would be best suited for their skin. Because DNA is very sensitive in nature when it comes to privacy, we need to transparently indicate to the consumer that his or her data is used exclusively for his or her own benefit rather than being irresponsibly sold to other companies behind-the-scenes. To do this, we could leverage the anonymous transparency feature of the blockchain ledger to create data provenance on the Ethereum network. This is a simple yet perfectly effective implementation of one of blockchain’s primary facets, without the overcomplicated gimmick of many other blockchain-based platforms out there.

Tokenization on the blockchain not only serves to provide data provenance or decentralization, but also to facilitate a platform economy with a user incentivization system. The interesting nature of digital tokens is the simultaneously inherent utility and the variable value of them. The tokens, in themselves, can be used to represent and drive supply-and-demand aspects of a business model on a blockchain-based platform.

Navigating the Regulatory Seas

Regulations involving ICOs have evolved extensively since they first appeared on the market. Despite the revolutionary, versatile nature of combining smart contract utility and value into a digital unit, the ease of transmission of the tokens to external wallets beyond the platform along with the rise of supporting exchanges for fiat liquidity, attracts speculative investors. Subsequently, the values of these tokens derived from speculative investing have far outpaced the true values of their utility. And that doesn’t sit well with the US Securities & Exchange Commission.

The first sign of scrutiny was when the SEC stated back in July that the DAO was in violation of securities laws, and went on to suggest its relevance to digital tokens and ICOs. The watershed moment was in December when the SEC halted the Munchee ICO, clearly describing how Munchee violated securities laws by promoting expectations of profits despite claiming its token was a utility token. There was now at last a somewhat clearer case for other US companies to base their offering structure on, namely SEC’s position that a token sale should be based on the “economic realities underlying a transaction”.

Given this, EpigenCare had to now carefully assess how it would structure its token sale offering. The three options typically available for a token sale were as follows: (1) sell them as a utility token; (2) offer them through a SAFT (Simple Agreement for Future Tokens) instrument; or (3) offer the tokens themselves as securities under an appropriate registration or exemption. As we hoped to clearly attract investors and we intended to offer securities to raise capital, Option 1 was promptly eliminated. As for the SAFT security instrument, we realized that it was just a medium into a security inappropriately disguised as a utility — so this was out. Option 3 was the clear choice: find an exemption for us to issue our tokens as securities under.

Legal Compliance

Looking at the available exemptions under SEC rules, we encountered three that would fit us well:

Regulation D 506(c) — Available for accredited US investors

Regulation S — Available for non-US investors, no accreditation requirements

Regulation CF — Available to both non-US investors and accredited US investors through an authorized crowdfunding platform with a $1,070,000 maximum

Each one has its pros and cons, with some requiring more paperwork than others. Each one permits general advertising about the offer, albeit with some legal nuances between each other. These exemptions also require a one-year holding period by investors before they could be freely traded. It turns out that this SEC requirement suits us quite well, as it gives us time to ensure we build out our business and prevent pump-and-dump shills from over-hyping and then crashing the value of our token. It would also provide us time to build out a relationship with trading platforms that are looking to offer compliant security tokens. In fact, one year is nothing to accredited and institutional investors. After laborious back and forth with our attorneys, we decided to offer our tokens under all three types of exemptions concurrently.*

*Regulation A+ was not selected due to the involved costs, time, labor, and permanent reporting requirements not suitable for an early stage startup.

All seemed ready to go, marketing budget ready to fire, and yet there was still a problem.

The Catch-22

In March, we realized a critical problem with tokens even if we were to go fully compliant with SEC regulations under an exemption (or even a registration) offering. Namely, if we were to mix (a) the allocated tokens for security issuance for fundraising together with (b) the allocated operational tokens under the exact same token type, then the operational tokens wouldn’t have a qualifying exemption since this batch was never “issued” under one. In other words, the investor tokens would never be able to flow into the platform, and the users of the platform would never be able to withdraw tokens to an external exchange. This is due to the fact that the platform users were never technically issued tokens under an exemption (e.g., users are gaining access to tradeable tokens through the platform yet never went through KYC/AML/Accreditation processes) and we wouldn’t be able to distinguish which tokens were which once mixed together. Thus, this disconnection means that the token value between traded markets and the platform use would be non-existent, nullifying the inherent tokenomics.

The dual function of utility and security in a single token was impossible to fit into the SEC’s current regulations, prompting us to look for an alternative solution. Until the SEC addresses the current law’s constraints for the novel technology of cryptographic tokens, we will have to find a way to make our platforms operational. This means we needed to design an explicit separation between the utility side and the security side of the token, and the only way to do that was to actually create two distinguishable tokens.

A Dual Token Structure

Our proposal is for our utility tokens called ECARE to be of fixed value and inflatable supply to act as loyalty points, a reward incentive, and a transactional associator of our generated epigenetic profiles with the data provenance aspects of the blockchain. ECARE would operate within the confines our ecosystem in a clear utility manner. Our second token, EPIC, is a security token, which offers an option to convert into equity shares to encapsulate the value of the company in its entirety. To bridge EPIC’s value with ECARE, all holders of EPIC would be entitled to an ongoing 5% revenue share of all ECARE-based transactions generated on the blockchain for our skincare testing and advertising sales. Additionally, the clear separation of EPIC as a security token allows it to be legally qualified to be traded on upcoming SEC-registered exchanges.

We have so far seen a few companies propose a dual token structure, and it appears that this is the most valid route to take to ensure full compliance with the SEC. In fact, we believe that this is the route that the Commission is implicitly guiding blockchain startups towards, at least in the meantime. StartEngine, the crowdfunding platform that is helping us carry out our Regulation CF offering, recognizes this trend. Their CEO Howard Marks recently wrote about the need to distinguish between security and utility, and emphasized the need for a dual token system. He further proposed two instruments RATE (Real Agreement for Tokens and Equity) and DATE (Debt Agreement for Tokens and Equity) which offers both utility tokens and security tokens representing equity shares.

The Future of Digital Tokens

It is becoming apparent that the existence of utility tokens is being threatened. We have seen exchanges such as Bittrex delist 82 tokens, probably as an emergency reaction to SEC’s series of crackdowns on players in the ICO market. This trend is likely to continue as utility tokens, even existing ones, become increasingly in the crosshairs of authorities. With investigatory revelation of the amount of fraud and lies that many unregulated ICOs have committed, such as the recent arrest of Centra Tech’s executives, the stronger regulation is much needed in the token sale and ICO space. The clean-up will tighten up company actions, eliminate the shell company schemes, instill investor confidence, and finally encourage legitimate startups in need of capital to successful raise money for real projects.

We have seen the value of the cryptocurrency market plummet from a record high of over $800 billion to $300 billion at the time of this writing. Although there are many forces at work, including a necessary correction from a parabolic rise, much of it is due to the sobering effects of regulatory activity and the realization that most of the previous ICO companies will unlikely achieve their roadmap milestones. As more tokens go to zero, we believe that investors will look for stronger investments in the crypto space which could result in another booming market for legally compliant cryptographic investment assets.

Companies like tZERO, and possibly Poloniex through their acquisition by Circle, are already seeking to become ATS (Alternative Trading System) exchanges that would be registered with the SEC so that they are authorized to trade crypto securities. As utility tokens become less liquid and continue to be removed from exchanges, more investors will likely turn to trading tokenized securities that are tied into a separate blockchain utility, and ultimately seek out instruments futureproofed for legal compliance.

It is apparent that the SEC is not hesitant to pursue previously completed ICOs, such as in Centra Tech’s case, which makes both existing utility tokens and new utility tokens offered by current ICOs on the market at risk of being investigated and shut down. Nearly all of these tokens, even ones boldly offered by daring US organizations, will likely fail to pass the test of the “economic realities of the underlying transaction”. To minimize risk for investors, it is probably best for them to concentrate their investments in compliant Security Token Offerings (STOs) with dual token structures.

If you liked this op-ed of EpigenCare, learn more about our business at https://www.epigencare.com and the detailed structure of our Security Token Offering (STO).

Personalization of skincare is only as good as the data you leverage
2018-03-28 23:03:34

Personalization of skincare is only as good as the data you leverage

EpigenCare’s prototype sample collection kit packaging for direct-to-consumer epigenetic testing of skin quality indicators.

Garbage in. Garbage out. Product suggestions made by personalized skincare companies are only as reliable as the data used in their recommendation systems. These data often fail to account for the fluctuating and dynamic quality of human skin, sourcing from product reviews, testimonials, and static genetic sequencing. Instead, we’re paving the way for true skincare personalization, and unlike many other companies, EpigenCare is doing it with the support of rigorous science. Using epigenetics, EpigenCare can measure the current status of a person’s skin quality to help suggest an effective and practical skincare regimen, one that can be tailored to the individual and even monitored over time for true personalization.

Many new personalized skincare companies offer product recommendations based on data that is biased and static, such as personal testimonials and marketing information. By scraping material from these sources and plugging it into their “smart” algorithms, they compile a database which essentially ignores the fluctuations of the skin’s characteristics. Product suggestions curated by these companies are based on unchanging factors, which does little to help create a skincare routine that should be responsive to, for example, the effect pollution or the changing seasons have on our skin.

Even companies that go a step further and look at an individual’s genetics cannot apply this data to actual personalization. Many genetic-based tests rely on genetic variants called single-nucleotide polymorphisms (SNPs), which are unable to be altered or reversed once established at birth. In fact, almost 40% of DNA results from genetic tests might be useless. It is impossible for ingredients in skincare products to biologically change or replace SNPs or any genes, in part or whole.

On the other hand, EpigenCare’s direct-to-consumer test takes into account the extra layer of dynamic information that lies above our DNA which can turn genes on or off. Epigenetics involves chemical tags that lead to a change in gene expression without affecting genotype. Unlike any other personalized skincare company, this shifting signature can even be collected over time to form a portfolio and develop progressive skincare regimens. Additionally, because epigenetics is tissue-specific, the test is based on DNA collected directly from skin (non-invasively) versus unreliable saliva.

Our skin is a dynamic landscape whose characteristics change depending on factors including stress, the environment, and age. Epigenetic tags may be adjusted in response to certain exposures. For instance, methyl groups may be added to or removed from genes related to skin quality, thereby reducing gene function at varying degrees. The sun’s rays, air pollution, and a consistently poor diet all have potential to modify these tags on our DNA.

Once a person’s current skin status is identified, EpigenCare can then connect their epigenetic signature to ingredients that have been shown to influence relevant epigenetic markers. Our personalized skincare recommendation engine — which selects from over 20,000 skincare products available on the market — relies on results from our own lab as well as thousands of peer-reviewed epigenetic studies that assess relevant skin quality indicators and the potential power of ingredients to influence these markers. Measuring the skin’s epigenetic changes over time is vital for determining the progress of a skincare regimen in order to fine-tune recommendations — and EpigenCare is the first to do so.

In the past, when searching for an ideal skincare product, women and men have turned to product reviews and testimonials. This method may have been suitable for the basic consumer, but it’s certainly not personalized. Now we’re able to take advantage of evolving technology, including next-generation sequencing and bioinformatics, which offers immense insight into the needs of diverse skin types and skin characteristics which vary over time.

EpigenCare’s science-backed method of personalized skincare utilizes advanced methylation sequencing technology and pulls from a plethora of peer-reviewed studies that contain independently verified data. We can suggest products based on an individual’s unique and changing epigenome in order to provide practical guidance for personalized and actionable skincare routines. Ultimately, monitoring the dynamic quality of a person’s skin fuels truly personalized skincare routine recommendations.

Investors can learn more about EpigenCare’s technology and business model at http://token.epigencare.com.

Let’s talk about epigenetics and personalized skincare
2018-02-23 17:23:59

Let’s talk about epigenetics and personalized skincare

A few days ago we revealed our project to the world through an official press release: a personalized skincare test based on epigenetics. Like 23andMe, it is a “collect-DNA-at-home-and-mail-it-in” type service. What makes the EpigenCare solution unique is that it is based on epigenetics, not genetics, which looks at active versus inactive genes to best assess the dynamic states of skin as well as environment stimuli that affects them. True personalization. In fact, the most exciting thing about our personal epigenomics test is that it generates actionable results — skincare product recommendations based on the ingredients’ effects on the epigenetic markers we’re looking at. This is in distinct contrast to other personalized tests that produce vague and obvious guidelines in their reports (e.g., sleep more, eat better, exercise, etc.).

Personalized skincare is gaining notable demand in recent years, with current offerings mostly based on personal consultation and genetic testing. Without a scientifically-grounded test to assess skin properties, consultation-based solutions can only identify a few skin types superficially and would be considered educated guesswork. This approach is typically too generalized such that most individuals receive very similar recommendations on skin care.

As for genetic-based tests for skin care, these methods often rely on a gene’s single-nucleotide polymorphism (SNP). SNPs are established at birth and cannot be altered or reversed during one’s entire life — they cannot be used to determine dynamic changes of functional genetic pathways which will affect skin quality status. Genetic-based testing is not able to monitor skin status changes from aging or exposure to the environment or chemicals, and consequently is not able to truly provide any practical guidance for personalized and actionable skincare routines.

Epigenetic-based skin profiling would the only feasible and real solution for both personalized and practical skincare. So what exactly is epigenetics? It mainly refers to the modification of DNA by adding a chemical tag (i.e., a methyl group) on DNA sites, which will cause genes to be switched on or off without changes to the actual underlying DNA sequence. This in turn will affect how genes are read by cells, and subsequently how they produce proteins.

Diagram of the chromatin structure, including histones and DNA, which become available to epigenetic marks.

Good skin quality and aesthetics, especially for the face and hands, are reflected by a youthful appearance and determined by multiple factors including the skin’s aging, firmness and elasticity, moisture, cell renewal and regeneration capacity, and antioxidant capacity. These factors are greatly affected by exposure of one’s skin to the environment and are epigenetically controlled/regulated. Environment stimuli, such as sun exposure or chemicals, will cause epigenetic changes (i.e., DNA methylation) of genes related to one or more of the mentioned factors in one’s skin cells. This leads to loss of gene function at varying degrees, thereby making each person’s skin quality unique.

People will self-collect DNA from their skin, not saliva, using a non-invasive method. Once mailed to our lab facilities, we use a proprietary targeted methylation sequencing method derived from next-generation sequencing applications such as reduced representation bisulfite sequencing as well as targeted bisulfite sequencing. Once sequenced, our bioinformatics pipeline analyzes a multi-panel of DNA methylation markers that best reflects the dynamic changes of major skin quality indicators.

Our panel of epigenetic markers was developed through the supporting effort of EpiGentek, a renowned supplier of epigenetic research reagents. These markers associated with skin quality indicators are well proven in many academic publications as well as in our own lab research. For example, the SEC31L2 gene, whose protein product regulates collagen secretion, is highly methylated in the skin of older individuals. Gene DDAH2, involved in structural and functional integrity of the epidermal layers, is hypermethylated in aging skin.

Identical twins have the exact same genetic sequence, yet will have entirely different DNA methylation levels, which can be reflected in the skin quality.

Based on our skincare test results, which identifies one’s unique skin profile from more than six billion possible skin status patterns, we provide personalized skincare product options algorithmically selected from over 20,000 skincare products available on the market. This means that folks no longer have to spend money on blindly selecting ineffective skincare products, while enabling the ability to dynamically monitor, track, and improve the progress of their skincare products or routine.

We should also mention how we’re dealing with the perceived privacy issues often associated with these direct-to-consumer tests requiring DNA. Epigenetic skin profiles from the tests will be anonymized using Ethereum’s blockchain ledger. Because skincare companies can leverage our algorithm to screen their products before being recommended to the user, we need to rely on the anonymous transparency feature of blockchain technology so that people will have traceable awareness of how their data is used for their own benefit, all the while without revealing any identities.

EpigenCare’s product pre-orders will launch during the summer of this year.

Investors can participate in EpigenCare’s crowdsale at: https://token.epigencare.com

Twitter

EpigenCare mentioned in analytical report "#Blockchain in Retail and Fast Moving Consumer Goods" https://t.co/zfuMTgdaM3 "...is particularly useful for controlling supply chains since every change to data, such as manufacturing dates and locations, can be tracked." #skincare https://t.co/CuMJa6dPsB

"The filing indicates EpigenCare's intention to develop a strong intellectual property (IP) portfolio, which will effectively protect the unique innovation of our epigenetic skin test when it enters the retail market." -Adam W. Li, MD, Ph.D. #skincare https://t.co/m7tJpjHZAo

RT @EricTopol: I'm glad that someone is on this: “share the common quest to unlock the potential in health care data, to deliver better out…

"Epigencare’s science-based #skincare goes straight to the people" #personalizedskincare #beauty https://t.co/ekGoyLeD8A

Looking forward to working with 83Bar to conduct some of our market research initiatives for personalized skincare based on epigenetic profiling. #skincare #personalisedcare #beauty https://t.co/yIAhm4vC0h

Today's the last day to #invest in our pre-seed Reg CF equity #crowdfunding offering at https://t.co/DzGcYq7XS3. Get a chance to own a piece of @epigencare and help change the #skincare industry, before we enter our private investment rounds. Thanks for your support!

"The filing indicates @EpigenCare's intention to develop a strong intellectual property portfolio, which will effectively protect the unique innovation of our #epigenetic #skin test when it enters the retail market." #skincare #skincareroutine #beauty https://t.co/tPzMVWME8Z

We were featured in EuroCosmetic Magazine's piece on #epigenetics and how it plays a role #skincare. If you have a subscription, access it at: https://t.co/jUasqr2UVA #skincareroutine #beauty #cosmetics https://t.co/CJfLka0RqJ

Hello to our fellow #skincare companies at @JLABS in #nyc: @Repairogen & Curie Company! https://t.co/H5HS9MTBKR

Just some of the @epigencare team hanging out at @JLABS. Thanks to @JNJInnovation for the awesome evening reception last week! There's no better place to research #epigenetics for #skincare than #NYC at the @nygenome center! https://t.co/58Sxqv34Xo

Congratulations to @JLABS residents and the @JNJInnovation team on the grand opening at the @nygenome center! We are excited to be part of the accelerator program and we look forward to the continued growth of life sciences innovation in New York. @JohnNosta https://t.co/WMct2WYv9B

As summer approaches, don't forget to protect your skin against excessive sun exposure. There is a strong relationship between DNA methylation (an #epigenetic mechanism), aging, and sun exposure. #skincareroutine #skincare #skin #beauty #summer #beach https://t.co/tGkmBG8CkW

Check out @Refinery29's writeup on epigenetics and #skincare, with a big mention of @epigencare: "It's an ambitious venture — and still in fundraising stages — but as far as truly personalized skin care goes, it's one of the most promising yet." #beauty https://t.co/CJnOnhYq52

Our CEO presented at @NYSCC @HappiMagazine Anti-Aging Conference on #epigenetics and #blockchain enforced data privacy for personal #skincare. "The data that #personalization algorithms are based on must be great from the start to set machine learning on the right trajectory" https://t.co/8edncV8KaP

The @HappiMagazine Anti-Aging Conference kicks off tomorrow morning at the @javitscenter in NYC! Make sure to catch @epigencare CEO William Lee give a talk on personalized #skincare, digital beauty solutions, and #blockchain privacy. https://t.co/F6zgXkNJbS

In this 6 minute podcast by @HappiMagazine, @epigencare CEO William Lee talks about our test and platform, cost and turnaround, benefits for #skincare companies, and #blockchain technology and consumer #dataprivacy. #beauty #skincareroutine #cosmetics https://t.co/oZ1PXxJ365

RT @CassandraReport: Only 37% of young people trust beauty/grooming companies. These brands are embracing customization to give consumers m…

The @JNJNews focus piece about EpigenCare is currently on Johnson & Johnson's homepage! If you haven't already, read the article at https://t.co/jtooQ8Hf37 #personalizedskincare #personalskincare #beauty #skincare #skincareroutine #blockchain #dna #cosmetics @JNJInnovation https://t.co/1OHOOL37wH

How does one know what a company does with the data? We use #blockchain to enforce responsible data usage, with data provenance transparency to show you that your data is being used solely for your own benefit. https://t.co/geFg1QyOnM #privacy #skincare #DNA #beauty #cosmetics https://t.co/11XiDEdV5E

Thanks to @SupplemenPolice for the review writeup about our product, platform, and investment offering! "One of the prime highlights of this platform is the epigenetic testing feature." #skincare #cosmetics #beauty #ico #skincareroutine #skincareregimen https://t.co/uRsNo4XvHz

"EpigenCare has adopted a complementary digital platform that unites the skin care company's customisable products via a matching algorithm." #skincare #skincareroutine #skin #skincareregimen #cosmetics #beauty https://t.co/0n3jOve5ak

Our security token offering just went live for $ETH contributors. This investment instrument pays revenue sharing and offers an option to convert to equity. Start now at https://t.co/L7JXJibk4e #invest #investor #skincare #ico #blockchain $BTC #investment #tokensale #tokensales https://t.co/xBvSnLDDl7

Our security token offering #STO with equity conversion option starts tomorrow. Investors can review our newly provided Offering Memorandum for more details. #skincare #blockchain #investing #investor #ico #invest https://t.co/FsSbWwNDva

Check out our personalized #skincare feature in @GCI_Magazine's digital issue, which talks about how we're using the #Ethereum #blockchain platform to create data provenance and incentivization mechanisms for recurring skin quality testing. #ico https://t.co/fLZWWbTVtG

Check out our spotlight on Johnson & Johnson's website for the future of personalized #skincare at https://t.co/jtooQ8Hf37 https://t.co/r8VRILNgRm

If you thought the skincare products you're using are all unique, guess again. The same formulation is used over & over, with a different label slapped on. Let EpigenCare's test identify the right product for your skin. #skincare #beauty #cosmetics #ico https://t.co/8QbPdulZLK

Here's a raw, unedited sneak peak video of what's in our at-home DNA test kit. Stick, seal, ship. Get your DNA directly from your skin epigenetically sequenced to determine the ideal products for your #skin. #skincare #skincareroutine #beauty #cosmetics https://t.co/IWAcP9xYuj

EpigenCare's #epigenetics expertise & tech has roots in @Epigentek, a biotech supplier of epigenetic research reagents and contract research services. Targeted methylation sequencing is the key to #skincare personalization. #realscience #blockchain #ico https://t.co/L6Wa6DgwVK

Our rating has just been upgraded to 8.9/10 on @Foundico! Learn more about our investment offering at https://t.co/L7JXJibk4e. https://t.co/9cxipFydK5 https://t.co/76OKzNZEaV

It looks like @trendhunter has found us! Personalized #skincare is trending, and we're at the forefront of it. #skincareroutine #skincareregimen #cosmetics #beauty #skincarethread #blockchain #skincaretips https://t.co/FENNqWFfSS

On May 15th, catch CEO William Lee at @HappiMagazine's 2018 Anti-Aging Conference in NYC: ”Addressing the Rise of Personalized Skin Care and Its Perceived Invasiveness Through New Digital Technologies.” #skincare #cosmetics #beauty #blockchain #privacy https://t.co/dBVyn57ExK

RT @cb_beautynews: EpigenCare crowned J&J's Digital QuickFire Challenge for Skin Care winner @epigencare @JNJNews https://t.co/QYAtVQvBMQ

See our official press release about our win in the recent Johnson & Johnson Innovation @JNJInnovation Digital Beauty Quickfire Challenge! We can't wait to be a part of @JLABS and bring our personalized #skincare to market! https://t.co/F97YdqZXJD

A structured ecosystem limits what companies can do with your data. By tokenizing data we can transparently show to you on the #blockchain that companies must use your data solely and anonymously to provide a personalized #skincare product to you. https://t.co/L7JXJibk4e https://t.co/dTAlpq8L4r

A structured ecosystem limits what companies can do with your data. By tokenizing data we can transparently show to you on the #blockchain that companies must use your data solely and anonymously to provide a personalized #skincare product to you. https://t.co/L7JXJibk4e https://t.co/nuNkR2XOWu

EpigenCare is using #blockchain to prove that the #epigenetic data generated is used exclusively and voluntarily for your own benefit -- in the form of personalized #skincare. Learn more about blockchain in just 2 minutes: https://t.co/erEeFEUJPE

Read our thoughts about how we stand out from other "personalization" companies when it comes to #skincare: https://t.co/7mWGNm6BFq #skincareroutine #skincarethread #skincaretips #skin #beauty #cosmetics #makeup

We are honored and humbled about our win at @JNJInnovation's skincare innovation challenge. We are looking forward to the future of truly personalized skincare! #skincare #skincaregimen #skincareroutine #blockchain #ArtificialIntelligence https://t.co/C6RQhVxpLX

RT @stacyamityfeld: Epigenetics, AI and blockchain driving @epigencare digital skincare solution #digitalbeauty #QuickFireChallenge @JLABS…

RT @JLABS: Using #blockchain to protect user data and let consumers see how their data is being used @epigencare #JLABSBay https://t.co/bN2…

RT @JLABS: William Lee, CEO of @epigencare presenting their solution to the question if your skincare products are really working. #JLABSB…

“Big data of epigenetic info on the skin will provide actual scientific basis used for machine-learning. Such A.I., combined with photo imaging, would be truly useful for identifying skin quality states in a simplified manner.” #skincare #blockchain #ico https://t.co/F65orqXHsA

"The next beauty tech disrupters are out there, and this Challenge will help us identify the most promising potential partners in the co-creation of meaningful, future-forward skin solutions." -Sebastien Guillon, president, global beauty, J&J #skincare https://t.co/89QTFO7g2b

We've been selected as a finalist in Johnson & Johnson Innovation's @JNJInnovation @JLABS digital beauty challenge for having an innovative skincare/beauty technology & business model! Please vote for us at: https://t.co/T5B5QTa9wo #skincare #beauty #cosmetics #Skin #Innovators

Our token crowdsale for US investors has just went live! This is the first legally compliant ICO offered under SEC's Reg CF that is open to unaccredited US investors! https://t.co/DzGcYq7XS3 #ICO #tokensale #crowdsale #Crowdfunding #crowdfund #skincare #beauty #epigenetics

"The current skin care sector offers a wide range of products.... Despite the claims made that these products have a scientific methodology to their development, consumers who use them use a non-scientific method to select them." #skincare #beauty #ico https://t.co/O0JYlB1Sx6

Our personal epigenomics test recommends existing skincare products on the market -- this means you can take action for a better skincare regimen right away! #skincare #skincareroutine #beauty #cosmetics #blockchain #ico https://t.co/bGF0gFhBwz

" 'To move forward, we need to address nature and nurture at the same time. EpigenCare gives us the tools to do that,' said James Wang, MD, board-certified dermatologist and dermapathologist. He adds: 'Personalized epigenetics is the new frontier in skincare.' " #skincare #ico https://t.co/sMUsN6ilfm

Looking at how much pseudoscience is out there when it comes to epigenetics, we're ready to do some serious DNA methylation sequencing to cut through the fluff. https://t.co/C36qV4kg8K #epigenetics #skincare #skincareroutine #beauty #cosmetics #genetics

Our CEO, William Lee, will speak at @HappiMagazine's Anti-Aging conference (May 15) in NYC's Javits Center about #blockchain's importance to protect consumer privacy as we advance into scientific personalization: https://t.co/F6zgXkNJbS #skincare #ico #ICOsInTheHouse #antiaging https://t.co/y7uX0OJXnr

"The company is indexing the ingredients of thousands of skincare products, ranging from name brand to boutique. The matching algorithm will then select the ingredients that would best for the customer’s skin." #skincare #skincareroutine #blockchain #ico https://t.co/TRxQenOfgS

"Now all EpigenCare needs is @IvankaTrump to sign on as a spokesmodel." Enjoyed the joke, @writers100! Sorry to disappoint though, but we're too focused on perfecting the scientific mechanisms of the product atm! #skincare #blockchain #personalized #ico https://t.co/QEaYPKambA

"Ingredient recommendations can be made based on a person’s unique epigenetic signature, which reveals factors like skin elasticity, pigmentation, DNA damage, and age." #skincare #skincareroutine #blockchain #ico #epigenetics https://t.co/lsJjwphsEf

"[EpigenCare] sends the report to the customer after several weeks. Consumers can also track and measure the progress of their skin once they start using the recommended products via a blockchain-based system." #skincare #ico #SkinCareThread #blockchain https://t.co/3RMlUNujc0

Learn why tokenization of data through blockchain tech helps protect consumer privacy when it comes to sensitive data such as DNA-based tests: https://t.co/oZcgG98wX9 @bbennett03 #blockchain #crypto #bitcoin #ICO https://t.co/ecR7IVJlym

Watch how EpigenCare connects Jane with personalized skincare products! Investors can learn more at https://t.co/fBmZUgZiWv #skincare #beauty #skincareroutine #cosmetics #blockchain #epigenetics https://t.co/Rie3w2MbLt

RT @Angela_Marz: Checkout how this company is using a personal epigenetics test to figure out whether that skincare product you're using i…

Read a bit more about how we use our panel of epigenetic markers and the ingredients that affect them to help determine personalized skincare product recommendations #epigenetics #skincare #beauty @DrJuliaCarroll @POPSUGARBeauty @Refinery29 @missylynn https://t.co/2s4ZeV226o

RT @MorissaSchwartz: Ladies, this is it. @epigencare is gonna sell a skincare test that will let me know EXACTLY which best skincare produc…

RT @SocietyCosChem: https://t.co/bjq04ywg9t

We are pleased to reveal our personalized skincare project, a direct-to-consumer test based on epigenetics with the privacy protection of blockchain tech. Our pre-ICO will begin in March for investors. #blockchain #bitcoin #ico $BTC $ETH https://t.co/knVAFN3qDg